Form 8-K - Current report:
SEC Accession No. 0000200406-22-000081
Filing Date
2022-10-18
Accepted
2022-10-18 07:54:56
Documents
18
Period of Report
2022-10-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20221018.htm   iXBRL 8-K 49443
2 EX-99.1 a2022q3exhibit991.htm EX-99.1 62603
3 EX-99.2 a2022q3exhibit992.htm EX-99.2 1375013
8 a3q22overallfinancialresula.jpg GRAPHIC 13005
9 a3q22regionalfinancialresua.jpg GRAPHIC 8201
10 a3q22salesbysegment002a.jpg GRAPHIC 10098
  Complete submission text file 0000200406-22-000081.txt   1802160

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20221018.xsd EX-101.SCH 3344
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20221018_def.xml EX-101.DEF 16876
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20221018_lab.xml EX-101.LAB 34315
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20221018_pre.xml EX-101.PRE 17676
12 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20221018_htm.xml XML 19554
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 221314910
SIC: 2834 Pharmaceutical Preparations